Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study

Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology Source Type: news